Mainstay Medical receives Australian approval for neurostimulation implant

Alan Condon -   Print  |
Listen

The Australian Therapeutic Goods Administration provided regulatory approval for Mainstay Medical's ReActiv8 system.

Three insights:

1. ReActiv8 is restorative neurostimulation implant used to treat chronic lumbar pain.

2. The implant stimulates nerves that supply the lumbar multifidus muscle to generate contraction of the muscle, which can help patients recover from chronic lumbar pain.

3. Mainstay Medical aims to have ReActiv8 included in the Australian Prostheses List for private reimbursement in the third quarter of 2020.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Whitepapers

Featured Podcast